NLS In a new job

The Board of Directors has appointed Professor Börje Haraldsson as CEO of the company. “I and the Board as a whole are delighted that Börje Haraldsson is expanding his involvement in Oncorena and takes on the role as CEO of the company. Oncorena is now entering a dynamic clinical phase where all R&D aspects will […]

The Swedish biopharmaceutical company has announced the appointment of two new members to its Board of Directors, Tara Heitner and Pete Zorn. “We are excited to welcome Tara and Pete to our Board,” says Adam Bruce, Founder and Chairman of the Board of TikoMed in a press release. “Tara and Pete are perfect fits for […]

The company’s CEO, Anders Månsson, announced in July his wish to leave his position with the company no later than after the 3-month stipulated notice period. “I wish Anders Månsson all the best in his new endeavours and sincerely thank him for his period as CEO of RhoVac. Anders did an excellent job, not least […]

The Board of Directors of IRLAB has appointed its current CEO, Nicholas Waters, to the role of Executive Vice President and Head of Research & Development and recruited Richard Godfrey as the new CEO. “With the new management structure and the recruitment of Richard Godfrey, we are strengthening our resources and expertise in both the […]

Idogen has announces that Anders Karlsson has decided to leave the company to move on to a CEO role in another Swedish biotechnology company. “It has been a privilege to lead Idogen for the past three years and I am convinced that the company’s competent board and employees will continue to deliver significant progress for […]

Elypta has announced the appointment of Volker Liebenberg as Chief Medical Officer. “We are truly delighted to have Dr. Liebenberg join the team. He brings a wealth of experience in IVD development to Elypta and shares our belief in the potential for liquid biopsies to drive early detection of cancer,” says Karl Bergman, Elypta CEO. […]